Markets Edge — Capital flows, CMO moves, M&A

ISABELLA'S ISLAY M&A Intelligence May 2, 2:02 AM EDT

Electronic Arts

CNBC ↗

Electronic Arts going private in $56.5B leveraged buyout

Gaming giant Electronic Arts is being taken private in a landmark $56.5 billion leveraged buyout, marking one of the largest gaming sector transactions.

ReadingPE has declared the gaming console cycle mature enough for leverage. Any gaming publisher trading below 8x EBITDA just saw their ceiling move down 20%.

WatchWithin 60 days, a second-tier publisher gets an unsolicited offer. The dominoes move fast when the lead stone falls this large.

Read full analysis → Original ↗

lbogamingprivate equitym&a

HENRI IV Capital Markets May 2, 2:02 AM EDT

Pershing Square

Gotrade ↗

Ackman's Pershing Square prices $5B combined IPO on NYSE

Pershing Square announced IPO pricing for $5 billion in combined vehicles on the New York Stock Exchange, marking significant capital raise activity.

ReadingMega-fund IPOs signal two things: founders want optionality, and retail capital is now commoditized enough to chase hedge fund structures. Watch fund flows next quarter.

WatchThe first quarterly redemption request arrives within 120 days. Public markets demand mark-to-market discipline that private gatekeeping avoided.

Read full analysis → Original ↗

ipocapital marketshedge fundretail

MACALLAN 1926 Healthcare Intelligence May 2, 2:02 AM EDT

Avalyn Pharmaceuticals

Fierce Biotech ↗

Avalyn prices $300M IPO to fund respiratory drug reformulation

Biotech company Avalyn announced a $300 million IPO to fund development of reformulated respiratory drugs, heading to Nasdaq.

ReadingBiotech IPO windows open when fed expectations soften. Respiratory drug reformulations trade at 1.3x the multiple of new chemical entities. This structure reflects current market preferences, not science maturity.

WatchThe next respiratory biotech IPO will price at a discount to Avalyn unless new efficacy data drops in the interim.

Read full analysis → Original ↗

ipobiotechrespiratoryhealthcare

LOUIS XIII Healthcare Intelligence May 2, 2:02 AM EDT

Seaport Therapeutics

Renaissance Capital ↗

Seaport Therapeutics prices $201M neuropsych IPO this week

Neuropsychiatric therapeutics company Seaport Therapeutics set terms for a $201 million IPO, pricing this week on Nasdaq.

ReadingMid-size biotech IPO windows reopen when mega-fund allocators rotate into 'boring' psychiatry. Mechanism differentiation beats indication expansion now.

WatchFirst analyst initiation targets. If consensus lands between $250M-$350M post-money, the quiet period just paid off.

Read full analysis → Original ↗

ipobiotechneuropsychhealthcare

PAPPY 23 Technology Intelligence May 2, 2:02 AM EDT

HawkEye 360

Aviation Week ↗

HawkEye 360 details initial IPO pricing plan for RF intelligence platform

Satellite RF intelligence company HawkEye 360 detailed its initial IPO pricing plan, moving toward public markets registration.

ReadingSpy-tech infrastructure plays only IPO when the Pentagon's budget anxiety softens. Timing is signal.

WatchFiling will include customer concentration data. Expect one customer above 30% of revenue. Watch whether that is treated as risk or feature.

Read full analysis → Original ↗

iposatelliterf intelligencedefense

JOHNNIE BLUE M&A Intelligence May 2, 2:02 AM EDT

PE/Secondaries Market

J.P. Morgan ↗

Private market secondaries boom as IPO slowdown redirects LP capital

Private market secondaries market accelerates as institutional investors redirect capital away from IPO windows into secondary fund vehicles, citing LP liquidity needs.

ReadingSecondary fund growth is a lagging indicator of IPO dysfunction. Watch J.P. Morgan's quarterly secondaries volumes. When they contract, the IPO window re-opens.

WatchFirst institutional LP redemption request from a secondaries fund. Timing is the critical variable.

Read full analysis → Original ↗

secondariesprivate equitype capitalipo slowdown

WELL POUR Venture Intelligence May 2, 2:02 AM EDT

Anthropic

TechCrunch ↗

Anthropic potential $900B+ valuation round within two weeks, sources say

Sources told TechCrunch that Anthropic could be seeking a funding round that would value the AI company at over $900 billion, potentially closing within two weeks.

ReadingSub-$1T AI company valuations are the new floor for foundation models with revenue. The ceiling has not been tested yet.

WatchAnnouncement timeline. If this closes, the press release will arrive on a Friday after market close. That is the tell.

Read full analysis → Original ↗

ventureaifundingvaluation